Abstract: An electrolyte membrane which comprises a cation exchange membrane made of a polymer having cation exchange groups and contains manganese ions is used as an electrolyte membrane for a polymer electrolyte fuel cell. In a case where the cation exchange membrane has sulfonic acid groups, the sulfonic acid groups are ion-exchanged, for example, with manganese ions so that manganese ions are contained preferably in an amount of from 0.5 to 30% of —S03? groups contained in the cation exchange membrane.

Abstract: To provide a novel compound which satisfies characteristics required for an optical anisotropic material and which is excellent in durability against blue laser light, a liquid crystal composition containing the compound, an optical anisotropic material employing the liquid crystal composition and an optical element.

Abstract: A subject for the invention is to form a coating film which has high transparency and excellent adhesion to organic base materials and retains long-lasting excellent effects concerning hydrophilicity, antifogging properties, droplet repellency, and antifouling properties. The invention relates to an inorganic coating composition capable of forming a hydrophilic coating film on an organic base material, the organic coating composition comprising alumina particles having an aggregate diameter in a dispersion medium of 20-400 nm and either a silicic acid oligomer or a colloidal silica, a surfactant, a water-miscible organic solvent which is capable of swelling or dissolving the organic base material and has a boiling point of 120° C. or higher at an atmospheric pressure of 0.

Abstract: A method for producing an optical element by bonding a plurality of optical member with an adhesive, which is capable of providing the optical element with sufficient optical performance and with such a sufficient bonding strength to prevent separation from being made at bonded portions, and of making alignment easily, is provided. The method for producing an optical element, which comprises bonding two or more optical members with an adhesive, is characterized in that at least one of confronting bonded surfaces on at least one pair of contact surfaces of the optical members is subjected to dry cleaning in such a state that at least a surface connecting to a bonded surface is masked, followed by applying a liquid adhesive as the adhesive on the cleaned surface and curing the liquid adhesive to bond the optical members.

Abstract: Moldings of fluoro rubbers produced by crosslinking a tetrafluoroethylene/propylene copolymer or a tetrafluoroethylene/propylene/vinylidene fluoride copolymer, which have metal contents of 1.5% by mass or below in terms of metal elements and are suitable for use applications necessitating clean environment, for example, manufacturing or carrier equipment for semiconductors, manufacturing equipment, carriers, or storage containers for food, or medical supplies.

Abstract: Concave grooves for forming a receiving layer for inkjet printing are provided at the inner peripheral and outer peripheral boundary portions of an application region on a disk substrate. The concave grooves are formed with a substantially V-shaped cross section, and with a depth d that is at least equal to the film thickness of the coating film within a central region between the concave grooves. A plurality of nozzles of a supply device is arrayed in a radial direction across the central region between the concave grooves, and a substantially constant quantity of coating liquid per unit of surface area is applied so as to form a coating film of a predetermined thickness. The applied coating liquid portions are flattened by a mutual leveling effect.

Abstract: The present invention provides: a first sealing material for semiconductor device which sealing material is excellent in plasma resistance and inexpensive; and a second sealing material for semiconductor device and a method of manufacturing this sealing material wherein the sealing material has a good surface smoothness and a good dimensional precision. The first sealing material contains a fluororubber as a rubber component wherein the fluororubber inevitably contains a cured product of a fluorine-based elastic copolymer of a specific composition. The second sealing material is obtained by crosslinking, with ionizing radiation, a fluororubber preform containing a fluororubber component (a) (comprising a specific fluorine-based elastic copolymer) and a non-elastic fluororesin component (b) (comprising a vinylidene fluoride (co)polymer) in a specific ratio.

Abstract: The transparent film-coated substrate includes a substrate and a transparent coating film formed on the surface of the substrate, the transparent coating film comprising (i) a matrix containing a silicone having a fluorine-substituted alkyl group, and (ii) inorganic compound particles comprising a shell, and a porous matter or a cavity enclosed therein, wherein the porous matter or the cavity remains unchanged in the formed transparent coating film.

Abstract: Disclosed is fluorocarbon-based dry etching gas which is free of global environmental problems and a dry etching method using a plasma gas obtained therefrom. The dry etching gas includes a fluorinated ether of carbon, fluorine, hydrogen and oxygen and having 2-6 carbon atoms.

Abstract: An agent for the prophylaxis or treatment of muscle tissue degeneration, containing, as an active ingredient, a quinoline compound of the formula (I): ##STR1## or a pharmaceutically acceptable salt. The prophylactic or therapeutic agent of muscle tissue degeneration of the present invention contains a quinoline compound of the formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient, and shows remarkable inhibitory or improving action on degeneration of the muscle tissues such as necrosis, fibrosis, calcification and the like. The agent is specifically useful for the prophylaxis and treatment of cardiomyopathy, muscular dystrophy, pulmonary fibrosis and the like.

Abstract: A product having reduced friction and improved abrasion resistance comprises a formed resin containing at least one fluorine-containing polymer which is exposed to an ionizing radiation. The formed resin may include from 1 to 100 weight percent of the fluorine-containing polymer in the form of powder, and from 99 to 0 percent of a high molecule polymer which is not exposed to the ionizing radiation. The fluorine-containing polymer is preferably exposed to the ionizing radiation for a total dose of from 1 KGy to 10 MGy in the absence of oxygen at a temperature not lower than the melting point of a starting fluorine-containing polymer.

Abstract: 2-Arylquinolines represented by formula (1): ##STR1## wherein R.sup.1, R.sup.3 to R.sup.9 each represents hydrogen, halogen, lower alkyl, cyclic lower alkyl, aryl, aralkyl, alkoxy or --C.sub.m F.sub.2m+1 ; R.sup.2 represents hydrogen, halogen, lower alkyl, cyclic lower alkyl, aryl, aralkyl, alkoxy, --C.sub.n F.sub.2n+1 or --CH.sub.2 Q, in which Q represents a monovalent organic group obtained by eliminating from an organic compound having --NH-- the hydrogen atom bonded to the nitrogen, or halogen; X represents halogen or hydrogen; Y represents nitro or amino which may be protected with a protecting group; and m and n each represents an integer of from 1 to 6; and processes for producing the 2-arylquinolines.

Abstract: The improved hybrid calcitonin has a peptide segment in human calcitonin and a peptide segment in calcitonin derived from animals other than humans, such as eel, salmon and chicken. Each of the human or human analog calcitonins and the calcitonins derived from animals other than humans may be either native calcitonin or an analog thereof. The hybrid calcitonin has the outstanding advantage that it exhibits biological activities as strong as eel, salmon and chicken calcitonin while causing no side effects including nausea, disorders in the functions of the digestive tract or antigenicity.

Abstract: Quinolin-2-yl benzoic acid compounds which are useful as intermediates of quinoline compounds having angiotensin II antagonist activity prepared by decarboxylating 2-(carboxyphenyl)-4-quinolinecarboxylic acid compounds in which a carboxyl group bonded to a phenyl group may be esterified, while a carboxyl group bonded to a quinoline ring is not esterified, and both rings may have one or more substituents inert to the decarboxylation reaction.

Abstract: Liquid crystal display 1 has a surface disposed in parallel with a surface of holographic concave mirror 2. Liquid crystal display 1 causes a revolution about a display center "d" of holographic concave mirror 2 in a back-and-forth direction as indicated by arrow .alpha.. In response to such revolution around holographic concave mirror 2, liquid crystal display 1 causes an autorotation about its vertical center "e" in the back-and-forth direction as indicated by arrow .beta..

Abstract: A quinoline compound represented by the formula (1) or a salt thereof: ##STR1## wherein the definition of each substituents are described in the specification, which have angiotensin II antagonism and hypotensive action and are useful as an agent for the prevention and treatment of cardiovascular system diseases such as hypertension, heart failure and the like.

Abstract: Herein disclosed are cosmetics having spherical silica containing an ultraviolet reflecting meterial surface-treated with platy N-lauroyl-L-lysine incorporated therein. According to the present invention, those cosmetics having spherical silica containing a conventional ultraviolet reflecting material blended therewith are improved in cosmetic functions such as spreadability upon application, lubricity upon application, smooth feeling on skins, adhesiveness to skins, water repellency, feeling, etc., maintaining the original ultraviolet screening effect.

Abstract: A quinoline compound represented by the formula (1) or a salt thereof: ##STR1## wherein the definition of each substituents are described in the specification, which have angiotensin II antagonism and hypotensive action and are useful as an agent for the prevention and treatment of cardiovascular system diseases such as hypertension, heart failure and the like.

Abstract: A method of pulling a crystal of a metal oxide is disclosed, in which the growth of the crystal is performed in a liquid phase having a composition which is different from the metal oxide and which contains components constituting the metal oxide. The liquid phase is in contact with a solid phase located at a position separated from the position at which the crystal of the metal oxide grows. The solid phase has a composition different from that of the metal oxide and supplies components constituting the metal oxide to the liquid phase.

Abstract: An isoindazole compound of the formula (1) or a salt thereof; a method for the production thereof; and pharmaceutical use of the compound and a salt thereof, particularly as an angiotensin II antagonist and as an agent for the prophylaxis and treatment of circulatory diseases (particularly hypertension and heart failure); ##STR1## wherein Q is a heterocyclic derivative of the formula (2) or (3) ##STR2## wherein other symbols of the above formulas are as defined in the Specification. The compound and its salt show superior angiotensin II antagonism and are low toxic. Accordingly, they are useful as angiotensin II antagonists for the treatment or prophylaxis of angiotensin II-mediated diseases such as circulatory diseases of hypertension (e.g. essential hypertension, renal hypertension) and heart failure.